Two Sigma Investments, LP Krystal Biotech, Inc. Transaction History

Two Sigma Investments, LP

  • $41.1 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$39.81 - $88.24 $425,290 - $942,667
-10,683 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$52.01 - $71.77 $555,622 - $766,718
10,683 New
10,683 $558,000
Q3 2020

Nov 16, 2020
SELL
$37.76 - $48.49 $251,217 - $322,603
-6,653 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$37.03 - $60.0 $246,360 - $399,180
6,653 New
6,653 $276,000

Others Institutions Holding KRYS

# of Institutions
275
Shares Held
24.9M
Call Options Held
270K
Put Options Held
172K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.54B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email